These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 24885814)
1. Prognostic factors for recurrence-free and overall survival after adrenalectomy for metastatic carcinoma: a retrospective cohort pilot study. Hwang EC; Hwang I; Jung SI; Kang TW; Kwon DD; Heo SH; Hwang JE; Kang SG; Kang SH; Lee JG; Kim JJ; Cheon J BMC Urol; 2014 May; 14():41. PubMed ID: 24885814 [TBL] [Abstract][Full Text] [Related]
2. Prognostic factors after adrenalectomy for adrenal metastasis. Goujon A; Schoentgen N; Betari R; Thoulouzan M; Vanalderwerelt V; Oumakhlouf S; Brichart N; Pradere B; Roumiguie M; Rammal A; Soulie M; Fournier G; Bensalah K; Bruyere F; Grise P; Joulin V; Manunta A; Saint F; Huyghe E; Nouhaud FX; Peyronnet B Int Urol Nephrol; 2020 Oct; 52(10):1869-1876. PubMed ID: 32419066 [TBL] [Abstract][Full Text] [Related]
3. Adrenal metastectomy is safe in selected patients. Romero Arenas MA; Sui D; Grubbs EG; Lee JE; Perrier ND World J Surg; 2014 Jun; 38(6):1336-42. PubMed ID: 24452292 [TBL] [Abstract][Full Text] [Related]
4. Factors related to improved clinical outcomes associated with adrenalectomy for metachronous adrenal metastases from solid primary carcinomas. Cho JW; Lee YM; Sung TY; Yoon JH; Chung KW; Hong SJ Surg Oncol; 2018 Mar; 27(1):18-22. PubMed ID: 29549899 [TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for survival after surgery for adrenal metastasis. Muth A; Persson F; Jansson S; Johanson V; Ahlman H; Wängberg B Eur J Surg Oncol; 2010 Jul; 36(7):699-704. PubMed ID: 20452170 [TBL] [Abstract][Full Text] [Related]
6. Adrenalectomy improves outcomes of selected patients with metastatic carcinoma. Vazquez BJ; Richards ML; Lohse CM; Thompson GB; Farley DR; Grant CS; Huebner M; Moreno J World J Surg; 2012 Jun; 36(6):1400-5. PubMed ID: 22411083 [TBL] [Abstract][Full Text] [Related]
7. Routine adrenalectomy in patients with locally advanced renal cell cancer does not offer oncologic benefit and places a significant portion of patients at risk for an asynchronous metastasis in a solitary adrenal gland. Weight CJ; Kim SP; Lohse CM; Cheville JC; Thompson RH; Boorjian SA; Leibovich BC Eur Urol; 2011 Sep; 60(3):458-64. PubMed ID: 21514718 [TBL] [Abstract][Full Text] [Related]
8. Outcome and prognostic factors after adrenalectomy for patients with distant adrenal metastasis. Howell GM; Carty SE; Armstrong MJ; Stang MT; McCoy KL; Bartlett DL; Yip L Ann Surg Oncol; 2013 Oct; 20(11):3491-6. PubMed ID: 23793361 [TBL] [Abstract][Full Text] [Related]
9. Treatment outcomes of percutaneous radiofrequency ablation versus adrenalectomy for adrenal metastases: a retrospective comparative study. Liu B; Mo C; Wang W; Ye J; Jiang C; Xie X; Huang J; Huang G; Long H; Xie X J Endocrinol Invest; 2020 Sep; 43(9):1249-1257. PubMed ID: 32166699 [TBL] [Abstract][Full Text] [Related]
11. Modified anatomical retroperitoneoscopic adrenalectomy for adrenal metastatic tumor: technique and survival analysis. Ma X; Li H; Zhang X; Huang Q; Wang B; Shi T; Hu D; Ai Q; Liu S; Gao J; Yang Y; Dong J; Zheng T Surg Endosc; 2013 Mar; 27(3):992-9. PubMed ID: 23239289 [TBL] [Abstract][Full Text] [Related]